Promising Dividend Stocks To Research - August 20th

Key Points

• MarketBeat identified seven high-volume dividend stocks to research: ProShares UltraPro Short QQQ (SQQQ), Equity Residential, Procter & Gamble, Chevron, Direxion Daily TSLA Bull 2X Shares, Target, and Pfizer.
• The list spans defensive and income-oriented companies—including Equity Residential, Procter & Gamble, Chevron, Target, and Pfizer—alongside leveraged exchange-traded products SQQQ and TSLL, which carry substantially different risk profiles.
• Dividend payments can provide income and potential appreciation, but they are not guaranteed and may be reduced or suspended; investors should research each security’s business, strategy, and risks before investing.

ProShares UltraPro Short QQQ, Equity Residential, Procter & Gamble, Chevron, Direxion Daily TSLA Bull 2X Shares, Target, and Pfizer are the seven Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of companies that regularly distribute a portion of their profits to shareholders, typically as cash payments called dividends. Investors may seek these stocks for a combination of ongoing income and potential price appreciation, although dividend payments are not guaranteed and can be reduced or suspended. These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Read Our Latest Research Report on SQQQ

Equity Residential (EQR)

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract affluent long-term renters. Equity Residential owns or has investments in 305 properties consisting of 80,683 apartment units, with an established presence in Boston, New York, Washington, D.C., Seattle, San Francisco and Southern California, and an expanding presence in Denver, Atlanta, Dallas/Ft.

Read Our Latest Research Report on EQR

Procter & Gamble (PG)

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read Our Latest Research Report on PG

Chevron (CVX)

Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant.

Read Our Latest Research Report on CVX

Direxion Daily TSLA Bull 2X Shares (TSLL)

Read Our Latest Research Report on TSLL

Target (TGT)

Target Corporation operates as a general merchandise retailer in the United States. The company offers apparel for women, men, boys, girls, toddlers, and infants and newborns, as well as jewelry, accessories, and shoes; and beauty and personal care, baby gear, cleaning, paper products, and pet supplies.

Read Our Latest Research Report on TGT

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Read Our Latest Research Report on PFE

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source